BRAF Mutations in Colorectal Cancer
John L. Marshall, MD, remarks on the burden of BRAF mutations in patients with colorectal cancer and comments on the impact of molecular status on therapy.

▶︎
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD

▶︎
BRAF Explained in Plain English

▶︎
Colorectal Cancer Debate: First Line BRAF V600E - Targeted Triplet

▶︎
MSI in CRC – Microsatellite instability in colorectal cancer–Please participate in our survey below!

▶︎
9 Colon Cancer Symptoms You Should NEVER Ignore (Doctor Explains)

▶︎
Conor Randall | They gave me 8 weeks to live now I'm cancer free

▶︎
Before you Start or Refuse Cancer Therapy- WATCH THIS!

▶︎
Optimizing Testing and Treatment of Patients with BRAFV600E-mutant mCRC in Community Practice

▶︎
BRAF-Mutated mCRC: From Diagnosis to Treatment

▶︎
STAGE 4 COLON CANCER AT 31 YRS OLD | my diagnosis story part 1

▶︎
Fenbendazole and Cancer: Evidence, Myths & Risks!

▶︎
Warning Signs of Colon Cancer You Should Never Ignore

▶︎
Trametinib (Mekinist) and BRAF V600 Cancer Therapy

▶︎
Oncogenetics - Mechanism of Cancer (tumor suppressor genes and oncogenes)

▶︎
BRAF V600E research update: Dr. Corcoran (2020)

▶︎
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras

▶︎
I Dismissed My Stage 4 Colorectal Cancer Symptoms For YEARS! “Blood in my stool”

▶︎
BRAF-Mutated Colorectal Cancer

▶︎
AI reveals 10 clues of early colon cancer

▶︎
